Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia

Mise à jour : Il y a 4 ans
Référence : NCT00268697

Femme et Homme

Extrait

The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with ezetimibe on cholesterol levels in subjects with primary dyslipidemia


Critère d'inclusion

  • Hypercholesterolemia


Liens